目的 对21-羟化酶缺乏症患儿及其父母的CYP21A2基因进行突变分析,为能有效进行产前诊断提供科学依据。方法 收集2013年8月-2015年12月就诊于柳州市妇幼保健院的14例21-羟化酶缺乏症患儿及其父母外周血,提取基因组DNA,采用Sanger测序及多重连接探针扩增技术(MLPA)分析CYP21A2基因的所有外显子及其两端侧翼序列,并通过父母的基因型进行验证,以此为依据进行胎儿的产前诊断。结果 14例先证者中共检出4种突变,不同形式的点突变占89.3%(25/28),分别为c.293-13C>G(46.4%)、c.518T>A(39.2%)、c.737delA(3.6%),缺失突变占10.7%,均为CYP21A2基因外显子1-3缺失。2例产前诊断胎儿均为携带者。结论 CYP21A2基因突变位点c.293-13C>G及c.518T>A是本地区21-羟化酶缺乏症的常见突变。Sanger测序联合多重连接探针扩增技术可以同时检测出CYP21A2基因的点突变和缺失突变,为疾病的确诊与临床表型的判断提供了可靠依据。
Abstract
Objective To analyze CYP21A2 mutations in 21-hydroxylase deficiency children and their parents,and to provide scientific evidence for effectively performing prenatal diagnosis. Methods Fourteen 21-hydroxylase deficiency patients and the parents from Liuzhou Municipal Maternity and Child Healthcare Hospital were enrolled from August 2013 to December 2015.The mutations of CYP21A2 and gross deletions were determined by PCR based Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA). Results Genetic analysis revealed 4 kinds of CYP21A2 mutations.Different forms of point mutations accounted for 89.3% (25/28),including c.293-13C>G (46.4%),c.518T>A (39.2%),and c.737delA (3.6%).Deletions accounted for 10.7% (3/28),all of which were CYP21A2 exon 1-3 deletion.Prenatal diagnosis revealed 2 cases were carriers. Conclusions CYP21A2 c.293-13C>G and c.518T>A are common mutations in local patients with 21-hydroxylase deficiency.Sanger sequencing combined with MLPA could identify both point mutation and deletions of CYP21A2,which may be a reliable method for molecular diagnosis of CAH.
关键词
先天性肾上腺皮质增生症 /
CYP21A2基因 /
点突变 /
缺失
Key words
congenital adrenal hyperplasia /
CYP21A2 /
point mutation /
deletion
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Merke DP,Bornstein SR.Congenital adrenal hyperplasia[J].Lancet,2005,365(9477):2125-2136.
[2] Wang R,Yu Y,Ye J,et al.21-Hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients:Genotype-phenotype correlation and identification of nine novel mutations[J].Steroids,2016,108:47-55.
[3] 中华预防医学会出生缺陷预防与控制专业委员会新生儿筛查学组,中国医师协会青春期医学专业委员会临床遗传学组,中华医学会儿科学分会内分泌遗传代谢学组.先天性肾上腺皮质增生症新生儿筛查共识[J].中华儿科杂志,2016,54(6):404-409.
[4] 孙菲,陈霞,刘炳丽,等.21-羟化酶缺乏症全基因测序诊断方法的建立[J].中华内分泌代谢杂志,2010,26(4):325-329. [5] New MI,Abraham M,Gonzalez B,et al.Genotype-phenotype correlation in 1507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency[J].Proc Natl Acad Sci USA,2013,110(7):2611-2616.
[6] Trapp CM,Speiser PW,Oberfield SE.Congenital adrenal hyperplasia:an update in children[J].Curr Opin Endocrinol Diabetes Obes,2011,18(3):166-170.
[7] 谢莉,潘莉珍,郑敏,等.新生儿先天性肾上腺皮质增生症筛查分析[J].中国新生儿科杂志,2013,28(6):375-378.
[8] Finkielstain GP,Chen W,Mehta SP,et al.Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J].J Clin Endocrinol Metab,2011,96(1):E161-E172.
基金
柳州市科学研究与技术开发计划项目(2014G020404)
PDF(588 KB)
